Related Experiment Video
Updated: Feb 18, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.3K
Rigorous Clinical Trial Design in Public Health Emergencies Is Essential
Susan S Ellenberg1, Gerald T Keusch2, Abdel G Babiker3
1Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Summary
Randomized clinical trials for Ebola treatments were deemed unethical but were feasible. Better planning and collaboration are crucial for future public health emergencies to gather definitive treatment evidence.
Area of Science:
- Public Health
- Infectious Diseases
- Clinical Research
Background:
- The 2014-2015 Ebola epidemic highlighted challenges in conducting clinical research.
- Ethical and logistical concerns were raised regarding randomized trials in resource-limited settings.
- Lack of consensus among aid organizations hindered collaborative research efforts.
Purpose of the Study:
- To assess the feasibility and ethical considerations of randomized clinical trials during the Ebola epidemic.
- To evaluate the impact of fragmented collaboration on research outcomes.
- To identify necessary improvements for future public health emergency research.
Main Methods:
- Review of arguments against and experiences with randomized trials during the epidemic.
- Analysis of collaboration dynamics among international health organizations.
- Examination of approvals and initiation of randomized trials by local ethics boards.
Main Results:
- Randomized trials were ethically approved and initiated despite challenging conditions.
- Disagreements and lack of consensus led to delayed studies and inconclusive evidence.
- The feasibility of conducting trials in crisis settings was demonstrated.
Conclusions:
- Randomized clinical trials are feasible even in severe epidemics with limited infrastructure.
- Enhanced collaboration and planning between research, humanitarian organizations, and communities are essential.
- Proactive measures during interepidemic periods are needed to ensure timely evidence generation for future health crises.
More Related Videos
Related Concept Videos
01:20Study Designs in Epidemiology
1.1K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.1K
01:16Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
01:11Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
01:12Hazard Ratio
638
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
638
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
488
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
488
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
165
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
165